Icon Wealth Partners’s GSK GSK Stock Holding History

Icon Wealth Partners’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$132K	Buy	+3,653	New	+$130K	0.02%	337
2020 Q4	–	Sell	-5,742	Closed	-$270K	–	274
2020 Q3	$270K	Sell	5,742 -12,844	-69%	-$644K	0.05%	212
2020 Q2	$948K	Buy	18,586 +10,568	+132%	+$542K	0.23%	87
2020 Q1	$380K	Sell	8,018 -1,124	-12%	-$60K	0.15%	75
2019 Q4	$537K	Buy	9,142 +15	+0.2%	+$834	0.17%	67
2019 Q3	$487K	Sell	9,127 -376	-4%	-$19.3K	0.17%	68
2019 Q2	$475K	Buy	9,503 +396	+4%	+$19.9K	0.17%	70
2019 Q1	$476K	Buy	9,107 +537	+6%	+$26.8K	0.18%	68
2018 Q4	$409K	Sell	8,570 -1,868	-18%	-$92K	0.2%	76
2018 Q3	$524K	Buy	10,438 +562	+6%	+$28.6K	0.22%	74
2018 Q2	$498K	Buy	9,876 +307	+3%	+$15.5K	0.21%	75
2018 Q1	$475K	Buy	9,569 +697	+8%	+$32.5K	0.25%	91
2017 Q4	$393K	Buy	+8,872	New	+$410K	0.19%	110

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Icon Wealth Partners's GSK Position: Q3 2023 in Review

Icon Wealth Partners opened a new position in GSK (GSK) in Q3 2023: 3,653 shares worth $132K. The stake represents 0.02% of the portfolio and ranks #337 among its holdings. This is a return to the name: Icon Wealth Partners previously reported a position in GSK as recently as Q3 2020.

Icon Wealth Partners first reported a position in GSK in Q4 2017 and has held it in 13 quarters since. The position peaked at $948K in Q2 2020. 846 funds tracked by Wall St. Rank hold GSK as of Q3 2023.

Icon Wealth Partners held 3,653 shares of GSK worth $132K as of Q3 2023.
GSK was a new Icon Wealth Partners position in Q3 2023.
GSK made up 0.02% of Icon Wealth Partners's portfolio in Q3 2023, its #337 holding.
Icon Wealth Partners first reported a position in GSK in Q4 2017 and has held it in 13 quarters since.
Icon Wealth Partners's GSK position peaked at $948K in Q2 2020.
846 funds tracked by Wall St. Rank held GSK as of Q3 2023.

Based on Icon Wealth Partners's 13F filing for Q3 2023, filed 14 Nov 2023.